1,3-Dibromopropane → 1-(3-Bromo-propyl)-1H-indazole

HRID 1293099ノート

反応式

HRID 1293099 の反応式
[Br:1][CH2:2][CH2:3][CH2:4]Br.[NH:6]1[C:14]2[C:9](=[CH:10][CH:11]=[CH:12][CH:13]=2)[CH:8]=[N:7]1.[OH-].[K+].C(OCC)(=O)C>CN(C=O)C.O>[Br:1][CH2:2][CH2:3][CH2:4][N:6]1[C:14]2[C:9](=[CH:10][CH:11]=[CH:12][CH:13]=2)[CH:8]=[N:7]1

参加物

7

反応物 4

HCID 80011,3-DibromopropaneHCID 8857Ethyl AcetateHCID 92211H-IndazoleHCID 14797Potassium Hydroxide

生成物 1

HCID 112649241-(3-Bromo-propyl)-1H-indazole収率 62.8%

試薬・触媒・溶媒 2

HCID 962Water溶媒HCID 6228Dimethylformamide溶媒

実験手順

1,3-Dibromopropane (508 μl, 5.0 mmol)) was dissolved in 10 mL DMF and placed in a 100 mL flask. Indazole (592 mg, 5.0 mmol) and KOH (282 mg, 5.0 mmol) were added and the suspension was stirred overnight at room temperature. Ethyl acetate (50 mL) and water (50 mL) were added. Phases were separated and the aqueous phase was re-extracted with ethyl acetate (50 mL). The combined organic phases were washed with brine, dried over magnesium sulphate and evaporated to dryness to produce 751 mg of a yellow oil. Crude product was further purified by column chromatography (0–10% methanol:dichloromethane) to produce pure 22 (169 mg, 14%).

後処理

  1. customplaced in a 100 mL flask
  2. customPhases were separated
  3. extractionthe aqueous phase was re-extracted with ethyl acetate (50 mL)
  4. washThe combined organic phases were washed with brine
  5. dry with materialdried over magnesium sulphate
  6. customevaporated to dryness

出典と根拠

ORDレコード
ord-283feb495c7f43b9b0e0ac5a3860bda1
出典データセット
uspto-grants-2007_07
特許番号
US07238713B2

反応ノート

読み込み中…